Absence of CCR5 on donor T cells accelerates GVHD.

被引：0
|
作者：
Wysocki, CA
Burkett, SB
Kirby, SL
McKinnon, K
Craven, R
Blazar, BR
Serody, JS
机构：
[1] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA
[2] Univ Minnesota, Div Blood & Marrow Transplantat, Minneapolis, MN USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5200
引用
收藏
页码：408B / 408B
页数：1
相关论文
共 50 条
  • [41] Metabolomics as an Approach to Characterise the Contrasting Roles of CCR5 in the Presence and Absence of Disease
    Rautenbach, Anandi
    Williams, Aurelia A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (04)
  • [42] Ex vivo Fas ligand treatment selectively eliminates T cells that mediate GVHD.
    Kashtan, Osnat
    Levitsky, Hyam I.
    Civin, Curt I.
    BLOOD, 2006, 108 (11) : 904A - 904A
  • [43] CCR5 GENE POLYMORPHISM AFFECTS THE RISK OF GvHD AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION FROM ALTERNATIVE DONOR: POLISH DONOR-RECIPIENT STUDY GROUP
    Bogunia-Kubik, Katarzyna
    Mizia, Sylwia
    Polak, Malgorzata
    Gronkowska, Anna
    Nowak, Jacek
    Kyrcz-Krzemien, Slawomira
    Markiewicz, Miroslaw
    Dzierzak-Mietla, Monika
    Olchowy, Wojciech
    Koclega, Anna
    Sobczyk-Kruszelnicka, Malgorzata
    Sedzimirska, Mariola
    Suchnicki, Krzysztof
    Duda, Dorota
    Lange, Janusz
    Mordak-Domagala, Monika
    Werkun, Joanna
    Koscinska, Katarzyna
    Jedrzejczak, Wieslaw Wiktor
    Torosian, Tigran
    Halaburda, Kazimierz
    Kaczmarek, Beata
    Rybarczyk, Patrycja
    Sepkowska, Karolina
    Hellmann, Andrzej
    Kucharska, Agnieszka
    Kowalczyk, Jerzy
    Drabko, Katarzyna
    Warzocha, Krzysztof
    Tomaszewska, Agnieszka
    Mika-Witkowska, Renata
    Dlugokecka, Agnieszka
    Gozdzik, Jolanta
    Mordel, Anna
    Lange, Andrzej
    TISSUE ANTIGENS, 2012, 79 (06): : 482 - 483
  • [44] CCR5 promotes the migration of pathological CD8+ T cells to the leishmanial lesions
    Sacramento, Lais Amorim
    Amorim, Camila Farias
    Lombana, Claudia G.
    Beiting, Daniel
    Novais, Fernanda
    Carvalho, Lucas P.
    Carvalho, Edgar M.
    Scott, Phillip
    PLOS PATHOGENS, 2024, 20 (05)
  • [45] Increased response to CCR5 binding chemokines in T cells heterozygous for GRK2
    Heijnen, CJ
    Vroon, A
    Lombardi, MS
    Mayor, F
    Caron, MG
    Kavelaars, A
    FASEB JOURNAL, 2004, 18 (04): : A471 - A471
  • [46] Protocol to identify the sex and CCR5 genotype of the human donor cells and tissues transplanted into humanized immune mice
    Rout, Saurav S.
    Lavender, Kerry J.
    STAR PROTOCOLS, 2025, 6 (01):
  • [47] Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template
    Sather, Blythe D.
    Ibarra, Guillermo S. Romano
    Sommer, Karen
    Curinga, Gabrielle
    Hale, Malika
    Khan, Iram F.
    Singh, Swati
    Song, Yumei
    Gwiazda, Kamila
    Sahni, Jaya
    Jarjour, Jordan
    Astrakhan, Alexander
    Wagner, Thor A.
    Scharenberg, Andrew M.
    Rawlings, David J.
    SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (307)
  • [48] High Frequency of CCR5 and CCR2 Expressing T Cells and Its Association with Acute Renal Allograft Rejection
    Gupta, S.
    Saxena, A.
    Dinda, A. K.
    Guleria, S.
    Mitra, D. K.
    TRANSPLANTATION, 2012, 94 (10) : 379 - 379
  • [49] CCR5: The Receptor That Unlocks the Door for HIV Entry into Cells
    Unutmaz, Derya
    JOURNAL OF IMMUNOLOGY, 2022, 208 (11): : 2459 - 2460
  • [50] Localization of CD4 and CCR5 in living cells
    Steffens, CM
    Hope, TJ
    JOURNAL OF VIROLOGY, 2003, 77 (08) : 4985 - 4991
12345